CMS Open Payments · Program Year 2024
Prime Surgical, LLC
Prime Surgical, LLC reported $40,498.13 across General Payments, Research, and Ownership to 316 physicians and teaching hospitals across 316 transactions.
- $40.5K
- All-tracks total
- 316
- Transactions
- 316
- Recipients
- +$12.7K
- General Payments vs PY2023
Prime Surgical, LLC reported $40,498.13 across all CMS Open Payments tracks (General + Research + Ownership) to 316 physicians and teaching hospitals in Program Year 2024 - ranking #1401 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $40,498.13, averaging $128.16 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer prime-surgical-llc Prime Surgical, LLC
$40.5K · #1401/1,925 · 0.0% industry · PY2024
- TOT $40.5K
- RANK #1401
- SHARE 0.0%
- TXN 316
- RCP 316
- CAT 4
- GEN $40.5K
- ΔGEN +$12.7K
- TOP1 8.6%
- PY 2024
Volume peers
Nearest volume peer: Inogen, Inc. ($40.6K)
Prime Surgical, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Prime Surgical, LLC's CMS-reported General Payments increased by $12.7K (+45.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PRIME SURGICAL, LLCPY2023: PRIME SURGICAL, LLCPY2024: Prime Surgical, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $27,766.68
- PY2024
- $40,498.13
What the Data Shows for Prime Surgical, LLC
In Program Year 2024, Prime Surgical, LLC reported $40,498.13 in payments to 316 physicians and teaching hospitals across 316 individual transactions, an average of $128.16 per transaction and $128.16 per recipient. That total places Prime Surgical, LLC at rank #1401 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $18.4K, accounting for 45.5% of this company's General Payments and 272 transactions.
General Payment Breakdown by Type
"Food and Beverage" leads Prime Surgical, LLC's 4-category general-payment breakdown at $18.4K, 45.5% of the reported total.
Prime Surgical, LLC reports 4 general-payment categories - the top three are Food and Beverage (45.5%), Travel and Lodging (43.5%), and Space Rental or Facility Fees (8.6%). The remaining 1 category make up 2.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Prime Surgical, LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $18.4K | 272 | 45.5% |
| Travel and Lodging | $17.6K | 27 | 43.5% |
| Space Rental or Facility Fees | $3.5K | 1 | 8.6% |
| Entertainment | $980.16 | 16 | 2.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $12,124.77 (29.9%) of $40,498.13 in this company's General Payments records across 172 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Prime Surgical, LLC
The five named recipients with the highest reported General Payments from this company
- 1
University Of Alabama Hospital
$3,500.00 across 1 reported transactions
- 2
Norman Waldrop
$3,482.11 across 7 reported transactions
- 3
William Krauss
$1,760.54 across 2 reported transactions
- 4
John Touliatos
$1,745.58 across 1 reported transactions
- 5
Terry Clay
$1,636.54 across 7 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Prime Surgical, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Prime Surgical, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Prime Surgical, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Titan Surgical Group, Llc
Mozarc Medical US LLC
GRT US Holding, Inc.
Henry Schein One, LLC
Cadwell Industries, INC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.